Viewing Study NCT05872204


Ignite Creation Date: 2025-12-24 @ 8:02 PM
Ignite Modification Date: 2025-12-25 @ 5:35 PM
Study NCT ID: NCT05872204
Status: RECRUITING
Last Update Posted: 2025-03-19
First Post: 2023-05-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Sponsor: Universitaire Ziekenhuizen KU Leuven
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module